Technical Analysis for CERT - Certara, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 9.76 | 2.20% | 0.21 |
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| New 52 Week Closing Low | Bearish | 2.20% | |
| Lower Bollinger Band Walk | Weakness | 2.20% | |
| New 52 Week Low | Weakness | 2.20% | |
| Below Lower BB | Weakness | 2.20% | |
| Lower Bollinger Band Touch | Weakness | 2.20% | |
| Oversold Stochastic | Weakness | 2.20% | |
| New 52 Week Closing Low | Bearish | -1.21% | |
| NR7 | Range Contraction | -1.21% | |
| NR7-2 | Range Contraction | -1.21% | |
| New 52 Week Low | Weakness | -1.21% |
| Alert | Time |
|---|---|
| Up 2% | 7 minutes ago |
| 60 Minute Opening Range Breakout | about 1 hour ago |
| Up 1% | about 1 hour ago |
| 60 Minute Opening Range Breakdown | about 3 hours ago |
| Down 1% | about 3 hours ago |
Free Daily (Stock) Chart Reading
- Earnings date: 11/06/2024
Certara, Inc. Description
Certara Inc. provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinincal and clinical research, regulatory submissions, and market access. It offers medicines to patients using biosimulation software and technology to transform drug discovery and development. The company also provides related technology-enabled services to guide its customers' new drugs through the regulatory submission process and into the market. Its technology-enabled services include mechanistic biosimulation, empirical biosimulation, drug development and regulatory strategy, clinical pharmacology, model-based meta-analysis, regulatory writing and medical communications, regulatory operations, and market access. The company serves biopharmaceutical companies and academic institutions. It has operations in the United States, Canada, Spain, Luxembourg, Portugal, the United Kingdom, Germany, France, the Netherlands, Denmark, Switzerland, Italy, Poland, Japan, the Philippines, India, and Australia. Certara Inc. was founded in 2008 and is headquartered in Princeton, New Jersey.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Life Sciences Health Sciences Pharmacy Medication Drug Discovery Pharmacology Drug Development Pharmaceutical Sciences Systems Biology Medical Communications
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 19.8702 |
| 52 Week Low | 9.55 |
| Average Volume | 1,312,809 |
| 200-Day Moving Average | 14.60 |
| 50-Day Moving Average | 10.82 |
| 20-Day Moving Average | 10.37 |
| 10-Day Moving Average | 10.41 |
| Average True Range | 0.43 |
| RSI (14) | 30.56 |
| ADX | 18.66 |
| +DI | 15.45 |
| -DI | 33.62 |
| Chandelier Exit (Long, 3 ATRs) | 10.15 |
| Chandelier Exit (Short, 3 ATRs) | 10.84 |
| Upper Bollinger Bands | 11.14 |
| Lower Bollinger Band | 9.60 |
| Percent B (%b) | -0.03 |
| BandWidth | 14.84 |
| MACD Line | -0.28 |
| MACD Signal Line | -0.21 |
| MACD Histogram | -0.0755 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 10.14 | ||||
| Resistance 3 (R3) | 10.20 | 10.07 | 10.04 | ||
| Resistance 2 (R2) | 10.07 | 9.92 | 10.04 | 10.00 | |
| Resistance 1 (R1) | 9.81 | 9.83 | 9.75 | 9.75 | 9.97 |
| Pivot Point | 9.68 | 9.68 | 9.65 | 9.65 | 9.68 |
| Support 1 (S1) | 9.42 | 9.53 | 9.36 | 9.36 | 9.13 |
| Support 2 (S2) | 9.29 | 9.44 | 9.26 | 9.10 | |
| Support 3 (S3) | 9.03 | 9.29 | 9.06 | ||
| Support 4 (S4) | 8.97 |
